摘要
目的:探讨肺癌不同治疗方案治疗效果的药物经济学分析。方法:74例肺癌患者,根据不同治疗方案随机分为A、B和C3组,运用药物经济学成本-效果分析方法对3组治疗方案进行回顾性分析、评价。结果:A组(CAP方案)有效率37.5％,1个疗程费用10080元,有效率每增加1个百分点成本为268.8元;B组(MVP方案)和C组(NP方案)有效率分别为54.5％和46.2％,1个疗程费用分别为19680元和27680元,有效率每增加1个百分点成本分别为361.1元和599.1元。B组方案优于A和C组。结论:药物经济学在优化治疗方案,指导合理用药,提高经济效益,节约卫生资源方面具有重要意义。
OBJECTIVE: To explore pharmacoeconomic analysis of different chemotherapy regimens in the treatment of lung cancer. METHODS: 74 patients with lung cancer were randomly divided into three groups group A、B and C based on different regimens. Then retrospective analysis and evaluation for these chemotherapy regimens was performed by using cost effectiveness analysis of pharmacoeconomics. RESULTS: The efficiency in group A was 37.5%, the cost of one course of treatment was 10 080 yuan (RMB), the cost for every increased 1 percent of efficiency was 268.8 yuan; The efficiency in group B and C were 54.5% and 46.2%; The cost of one course of treatment was 19 680 and 27 680 yuan; The cost for every increased 1 percent of efficiency was 361.1 and 599.1 yuan respectively. The regimen in group B(regimen MVP) was better than that in group A and C. CONCLUSION: Pharmacoeconomics plays an important part in selecting chemotherapy regimens, guiding rational drug usage, raising economic benefit and saving hygienic resources.
出处
《中国医院用药评价与分析》
2004年第1期43-44,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
